Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001411690-25-000046
Filing Date
2025-05-14
Accepted
2025-05-14 16:11:22
Documents
75
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bngo-20250331.htm   iXBRL 10-Q 1698624
2 EX-31.1 bngo-20250331xexx311.htm EX-31.1 10316
3 EX-32.1 bngo-20250331xexx321.htm EX-32.1 7982
  Complete submission text file 0001411690-25-000046.txt   9023190

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bngo-20250331.xsd EX-101.SCH 56376
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bngo-20250331_cal.xml EX-101.CAL 97182
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bngo-20250331_def.xml EX-101.DEF 324702
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bngo-20250331_lab.xml EX-101.LAB 802908
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bngo-20250331_pre.xml EX-101.PRE 575777
78 EXTRACTED XBRL INSTANCE DOCUMENT bngo-20250331_htm.xml XML 1252647
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38613 | Film No.: 25945600
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)